211 related articles for article (PubMed ID: 12755697)
61. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions.
Yun BG; Huang W; Leach N; Hartson SD; Matts RL
Biochemistry; 2004 Jun; 43(25):8217-29. PubMed ID: 15209518
[TBL] [Abstract][Full Text] [Related]
62. Hsp90 interaction with clients.
Karagöz GE; Rüdiger SG
Trends Biochem Sci; 2015 Feb; 40(2):117-25. PubMed ID: 25579468
[TBL] [Abstract][Full Text] [Related]
63. The molecular chaperone gp96/GRP94 interacts with Toll-like receptors and integrins via its C-terminal hydrophobic domain.
Wu S; Hong F; Gewirth D; Guo B; Liu B; Li Z
J Biol Chem; 2012 Feb; 287(9):6735-42. PubMed ID: 22223641
[TBL] [Abstract][Full Text] [Related]
64. Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2.
Olesen SH; Ingles DJ; Zhu JY; Martin MP; Betzi S; Georg GI; Tash JS; Schönbrunn E
Molecules; 2015 Jan; 20(1):1643-60. PubMed ID: 25608045
[TBL] [Abstract][Full Text] [Related]
65. A putative consensus sequence for the nucleotide-binding site of annexin A6.
Bandorowicz-Pikula J; Kirilenko A; van Deursen R; Golczak M; Kühnel M; Lancelin JM; Pikula S; Buchet R
Biochemistry; 2003 Aug; 42(30):9137-46. PubMed ID: 12885247
[TBL] [Abstract][Full Text] [Related]
66. A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.
Gano JJ; Simon JA
Mol Cell Proteomics; 2010 Feb; 9(2):255-70. PubMed ID: 19875381
[TBL] [Abstract][Full Text] [Related]
67. Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain.
Fang L; Ricketson D; Getubig L; Darimont B
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18487-92. PubMed ID: 17130446
[TBL] [Abstract][Full Text] [Related]
68. Evolutionary epitopes of Hsp90 and p23: implications for their interaction.
Zhu S; Tytgat J
FASEB J; 2004 Jun; 18(9):940-7. PubMed ID: 15173105
[TBL] [Abstract][Full Text] [Related]
69. Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
Gavenonis J; Jonas NE; Kritzer JA
Bioorg Med Chem; 2014 Aug; 22(15):3989-93. PubMed ID: 24984936
[TBL] [Abstract][Full Text] [Related]
70. Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor.
Tassone G; Mazzorana M; Mangani S; Petricci E; Cini E; Giannini G; Pozzi C; Maramai S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012721
[TBL] [Abstract][Full Text] [Related]
71. ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.
Walerych D; Gutkowska M; Klejman MP; Wawrzynow B; Tracz Z; Wiech M; Zylicz M; Zylicz A
J Biol Chem; 2010 Oct; 285(42):32020-8. PubMed ID: 20688913
[TBL] [Abstract][Full Text] [Related]
72. Localization of sites of interaction between p23 and Hsp90 in solution.
Martinez-Yamout MA; Venkitakrishnan RP; Preece NE; Kroon G; Wright PE; Dyson HJ
J Biol Chem; 2006 May; 281(20):14457-64. PubMed ID: 16565516
[TBL] [Abstract][Full Text] [Related]
73. Nucleotide binding by the epidermal growth factor receptor protein-tyrosine kinase. Trinitrophenyl-ATP as a spectroscopic probe.
Cheng K; Koland JG
J Biol Chem; 1996 Jan; 271(1):311-8. PubMed ID: 8550578
[TBL] [Abstract][Full Text] [Related]
74. Nucleotide Binding and Active Site Gate Dynamics for the Hsp90 Chaperone ATPase Domain from Benchtop and High Field
Rashid S; Lee BL; Wajda B; Spyracopoulos L
J Phys Chem B; 2020 Apr; 124(15):2984-2993. PubMed ID: 32212608
[TBL] [Abstract][Full Text] [Related]
75. Autophosphorylation of grp94 (endoplasmin).
Csermely P; Miyata Y; Schnaider T; Yahara I
J Biol Chem; 1995 Mar; 270(11):6381-8. PubMed ID: 7890776
[TBL] [Abstract][Full Text] [Related]
76. Thermodynamic analysis of interactions of the Hsp90 with adenosine nucleotides: A comparative perspective.
Minari K; de Azevedo ÉC; Kiraly VTR; Batista FAH; de Moraes FR; de Melo FA; Nascimento AS; Gava LM; Ramos CHI; Borges JC
Int J Biol Macromol; 2019 Jun; 130():125-138. PubMed ID: 30797004
[TBL] [Abstract][Full Text] [Related]
77. Filter binding assay for the geldanamycin-heat shock protein 90 interaction.
Carreras CW; Schirmer A; Zhong Z; Santi DV
Anal Biochem; 2003 Jun; 317(1):40-6. PubMed ID: 12729599
[TBL] [Abstract][Full Text] [Related]
78. The C-terminal half of heat shock protein 90 represents a second site for pharmacologic intervention in chaperone function.
Marcu MG; Neckers LM
Curr Cancer Drug Targets; 2003 Oct; 3(5):343-7. PubMed ID: 14535286
[TBL] [Abstract][Full Text] [Related]
79. Elucidation of the Hsp90 C-terminal inhibitor binding site.
Matts RL; Dixit A; Peterson LB; Sun L; Voruganti S; Kalyanaraman P; Hartson SD; Verkhivker GM; Blagg BS
ACS Chem Biol; 2011 Aug; 6(8):800-7. PubMed ID: 21548602
[TBL] [Abstract][Full Text] [Related]
80. Insight into the Nucleotide Based Modulation of the Grp94 Molecular Chaperone Using Multiscale Dynamics.
Alao JP; Obaseki I; Amankwah YS; Nguyen Q; Sugoor M; Unruh E; Popoola HO; Tehver R; Kravats AN
J Phys Chem B; 2023 Jun; 127(24):5389-5409. PubMed ID: 37294929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
